| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | tubulin binding | TPR MID2 CEP295NL TOGARAM1 STMND1 TUBGCP4 CCDC61 GLI1 MID1 KLC3 | 7.36e-05 | 428 | 103 | 10 | GO:0015631 |
| GeneOntologyMolecularFunction | coumarin 7-hydroxylase activity | 7.88e-05 | 3 | 103 | 2 | GO:0008389 | |
| GeneOntologyMolecularFunction | microtubule binding | 1.96e-04 | 308 | 103 | 8 | GO:0008017 | |
| GeneOntologyBiologicalProcess | centriole assembly | 6.07e-06 | 53 | 101 | 5 | GO:0098534 | |
| GeneOntologyBiologicalProcess | regulation of microtubule-based process | 1.39e-05 | 293 | 101 | 9 | GO:0032886 | |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | TPR CEP295NL RTTN TOGARAM1 STMND1 TUBGCP4 CCDC61 CEP68 KAT2B CEP72 MID1 PKD1 SENP6 | 4.95e-05 | 720 | 101 | 13 | GO:0000226 |
| GeneOntologyBiologicalProcess | microtubule-based process | TPR CEP295NL RTTN LAMP1 TOGARAM1 STMND1 TUBGCP4 CCDC61 WDPCP CEP68 KAT2B CEP72 MID1 PKD1 SENP6 KLC3 | 5.38e-05 | 1058 | 101 | 16 | GO:0007017 |
| GeneOntologyBiologicalProcess | centriole replication | 8.22e-05 | 47 | 101 | 4 | GO:0007099 | |
| GeneOntologyCellularComponent | microtubule organizing center | CEP295NL RTTN TRIOBP MARCHF7 TOGARAM1 TUBGCP4 CCDC61 CEP68 FRY KAT2B PLEKHG6 CEP72 KIAA1217 MID1 TOP2A CPEB1 | 8.19e-06 | 919 | 101 | 16 | GO:0005815 |
| GeneOntologyCellularComponent | centrosome | CEP295NL RTTN TRIOBP MARCHF7 TUBGCP4 CCDC61 CEP68 FRY KAT2B PLEKHG6 CEP72 KIAA1217 MID1 CPEB1 | 1.98e-05 | 770 | 101 | 14 | GO:0005813 |
| Domain | TF_fork_head_CS_2 | 1.10e-04 | 46 | 101 | 4 | IPR030456 | |
| Domain | TF_fork_head_CS_1 | 1.20e-04 | 47 | 101 | 4 | IPR018122 | |
| Domain | FH | 1.42e-04 | 49 | 101 | 4 | SM00339 | |
| Domain | FORK_HEAD_1 | 1.42e-04 | 49 | 101 | 4 | PS00657 | |
| Domain | FORK_HEAD_2 | 1.42e-04 | 49 | 101 | 4 | PS00658 | |
| Domain | Fork_head_dom | 1.42e-04 | 49 | 101 | 4 | IPR001766 | |
| Domain | FORK_HEAD_3 | 1.42e-04 | 49 | 101 | 4 | PS50039 | |
| Domain | Forkhead | 1.42e-04 | 49 | 101 | 4 | PF00250 | |
| Domain | CTNNB1-bd_N | 1.73e-04 | 4 | 101 | 2 | IPR013558 | |
| Domain | Cyt_P450_E_grp-I_CYP2A-like | 1.73e-04 | 4 | 101 | 2 | IPR008067 | |
| Domain | CTNNB1_binding | 1.73e-04 | 4 | 101 | 2 | PF08347 | |
| Domain | TCF/LEF | 1.73e-04 | 4 | 101 | 2 | IPR024940 | |
| Domain | COS_domain | 1.84e-03 | 12 | 101 | 2 | IPR017903 | |
| Domain | COS | 1.84e-03 | 12 | 101 | 2 | PS51262 | |
| Domain | LDLRA_2 | 2.36e-03 | 49 | 101 | 3 | PS50068 | |
| Domain | - | 2.80e-03 | 52 | 101 | 3 | 2.60.120.290 | |
| Domain | Bbox_C | 2.90e-03 | 15 | 101 | 2 | IPR003649 | |
| Domain | BBC | 2.90e-03 | 15 | 101 | 2 | SM00502 | |
| Domain | CUB_dom | 3.63e-03 | 57 | 101 | 3 | IPR000859 | |
| Domain | PH | 4.01e-03 | 278 | 101 | 6 | SM00233 | |
| Domain | PH_DOMAIN | 4.08e-03 | 279 | 101 | 6 | PS50003 | |
| Domain | PH_domain | 4.16e-03 | 280 | 101 | 6 | IPR001849 | |
| Domain | - | 5.16e-03 | 20 | 101 | 2 | 3.30.565.10 | |
| Domain | - | 5.33e-03 | 391 | 101 | 7 | 2.30.29.30 | |
| Domain | HATPase_C | 5.69e-03 | 21 | 101 | 2 | IPR003594 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_NNK_TO_DNA_ADDUCTS | 1.89e-04 | 5 | 62 | 2 | M47808 | |
| Pathway | KEGG_THYROID_CANCER | 2.73e-04 | 29 | 62 | 3 | M523 | |
| Pathway | REACTOME_RUNX3_REGULATES_WNT_SIGNALING | 2.82e-04 | 6 | 62 | 2 | MM15542 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SALMONELLA_AVRA_TO_BETA_CATENIN_SIGNALING_PATHWAY | 2.82e-04 | 6 | 62 | 2 | M47736 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_KSHV_LANA_TO_WNT_SIGNALING_PATHWAY | 3.94e-04 | 7 | 62 | 2 | M47465 | |
| Pathway | REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_CELL_CYCLE_AND_PROLIFERATION | 5.24e-04 | 8 | 62 | 2 | MM17229 | |
| Pathway | REACTOME_BINDING_OF_TCF_LEF_CTNNB1_TO_TARGET_GENE_PROMOTERS | 5.24e-04 | 8 | 62 | 2 | M27359 | |
| Pathway | KEGG_MEDICUS_VARIANT_CDH1_REDUCED_EXPRESSION_TO_BETA_CATENIN_SIGNALING_PATHWAY | 5.24e-04 | 8 | 62 | 2 | M47413 | |
| Pathway | REACTOME_RUNX3_REGULATES_WNT_SIGNALING | 5.24e-04 | 8 | 62 | 2 | M27821 | |
| Pubmed | Neural transcription factors bias cleavage stage blastomeres to give rise to neural ectoderm. | 1.26e-09 | 6 | 107 | 4 | 27092474 | |
| Pubmed | The mouse fkh-2 gene. Implications for notochord, foregut, and midbrain regionalization. | 5.87e-09 | 8 | 107 | 4 | 8530406 | |
| Pubmed | An amphioxus winged helix/forkhead gene, AmphiFoxD: insights into vertebrate neural crest evolution. | 1.05e-08 | 9 | 107 | 4 | 12412011 | |
| Pubmed | A genetic study of the suppressors of the Engrailed-1 cerebellar phenotype. | 5.93e-08 | 13 | 107 | 4 | 16884697 | |
| Pubmed | 5.93e-08 | 13 | 107 | 4 | 7957066 | ||
| Pubmed | Six members of the mouse forkhead gene family are developmentally regulated. | 1.13e-07 | 15 | 107 | 4 | 7689224 | |
| Pubmed | 1.13e-07 | 15 | 107 | 4 | 22045912 | ||
| Pubmed | Expression of the winged helix genes fkh-4 and fkh-5 defines domains in the central nervous system. | 1.50e-07 | 16 | 107 | 4 | 8861101 | |
| Pubmed | 1.50e-07 | 16 | 107 | 4 | 10208738 | ||
| Pubmed | 2.82e-07 | 5 | 107 | 3 | 12234674 | ||
| Pubmed | Functional equivalency between Otx2 and Otx1 in development of the rostral head. | 3.17e-07 | 19 | 107 | 4 | 9895322 | |
| Pubmed | 3.95e-07 | 20 | 107 | 4 | 12812790 | ||
| Pubmed | 4.87e-07 | 21 | 107 | 4 | 9449667 | ||
| Pubmed | 5.93e-07 | 22 | 107 | 4 | 17389379 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | TPR BCLAF1 ZNF507 TATDN2 MCM4 PACS1 CTR9 RBMX2 CBFA2T2 MDC1 SENP6 RIMS1 TOP2A | 7.88e-07 | 774 | 107 | 13 | 15302935 |
| Pubmed | Otx2 is required to respond to signals from anterior neural ridge for forebrain specification. | 8.58e-07 | 24 | 107 | 4 | 11820816 | |
| Pubmed | 8.58e-07 | 24 | 107 | 4 | 29992973 | ||
| Pubmed | Ssdp1 regulates head morphogenesis of mouse embryos by activating the Lim1-Ldb1 complex. | 1.20e-06 | 26 | 107 | 4 | 15857913 | |
| Pubmed | 1.90e-06 | 29 | 107 | 4 | 22972626 | ||
| Pubmed | Genome-scale study of transcription factor expression in the branching mouse lung. | 2.08e-06 | 67 | 107 | 5 | 22711520 | |
| Pubmed | Hippocampus development and generation of dentate gyrus granule cells is regulated by LEF1. | 6.10e-06 | 12 | 107 | 3 | 10631168 | |
| Pubmed | CYP2A6 CYP2A13 CCDC185 NOC2L BCLAF1 PCLO HP1BP3 SCML4 NRXN3 SACS CTR9 RBMX2 DGKK SCN9A RIMS1 TOP2A | 8.67e-06 | 1442 | 107 | 16 | 35575683 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 23943798 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 26945969 | ||
| Pubmed | Evaluation of inhibition selectivity for human cytochrome P450 2A enzymes. | 9.38e-06 | 2 | 107 | 2 | 22696418 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 30876690 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 21395539 | ||
| Pubmed | Species differences in coumarin metabolism: a molecular modelling evaluation of CYP2A interactions. | 9.38e-06 | 2 | 107 | 2 | 12162851 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 1302041 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 8395817 | ||
| Pubmed | Mid1/Mid2 expression in craniofacial development and a literature review of X-linked opitz syndrome. | 9.38e-06 | 2 | 107 | 2 | 26788540 | |
| Pubmed | Absence of cytochrome P450 2A5 enhances alcohol-induced liver injury in mice. | 9.38e-06 | 2 | 107 | 2 | 25804444 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 1520280 | ||
| Pubmed | Restricted high level expression of Tcf-4 protein in intestinal and mammary gland epithelium. | 9.38e-06 | 2 | 107 | 2 | 9916915 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 23917075 | ||
| Pubmed | Nicotine enhances alcoholic fatty liver in mice: Role of CYP2A5. | 9.38e-06 | 2 | 107 | 2 | 30222954 | |
| Pubmed | Up-regulation of CYP2A5 expression by porphyrinogenic agents in mouse liver. | 9.38e-06 | 2 | 107 | 2 | 7543189 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 27902773 | ||
| Pubmed | Characterization and regulation of sex-specific mouse steroid hydroxylase genes. | 9.38e-06 | 2 | 107 | 2 | 2372744 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 21473878 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 7581481 | ||
| Pubmed | A gene family of HMG-box transcription factors with homology to TCF-1. | 9.38e-06 | 2 | 107 | 2 | 1741298 | |
| Pubmed | Circadian Regulation of Hepatic Cytochrome P450 2a5 by Peroxisome Proliferator-Activated Receptor γ. | 9.38e-06 | 2 | 107 | 2 | 30154104 | |
| Pubmed | Interstrain differences in the expression and activity of Cyp2a5 in the mouse liver. | 9.38e-06 | 2 | 107 | 2 | 28298240 | |
| Pubmed | Genetic polymorphisms for a phenobarbital-inducible cytochrome P-450 map to the Coh locus in mice. | 9.38e-06 | 2 | 107 | 2 | 6309775 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 21418183 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 22262919 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 25635819 | ||
| Pubmed | Genetic variation between mice in their metabolism of coumarin and its derivatives. | 9.38e-06 | 2 | 107 | 2 | 566237 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 19923441 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 12499123 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 8611142 | ||
| Pubmed | Function and regulation of the Cyp2a5/CYP2A6 genes in response to toxic insults in the liver. | 9.38e-06 | 2 | 107 | 2 | 22497566 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 665441 | ||
| Pubmed | Essential role of the cytochrome P450 enzyme CYP2A5 in olfactory mucosal toxicity of naphthalene. | 9.38e-06 | 2 | 107 | 2 | 24104196 | |
| Pubmed | The role of CYP2A5 in liver injury and fibrosis: chemical-specific difference. | 9.38e-06 | 2 | 107 | 2 | 26363552 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 2712571 | ||
| Pubmed | hnRNPH1 recruits PTBP2 and SRSF3 to modulate alternative splicing in germ cells. | 2.65e-05 | 19 | 107 | 3 | 35739118 | |
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 18602936 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 17607356 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 18068688 | ||
| Pubmed | Regulation of bile acid metabolism in mouse models with hydrophobic bile acid composition. | 2.81e-05 | 3 | 107 | 2 | 31645370 | |
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 3219345 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 3346244 | ||
| Pubmed | Zfp30, a KRAB domain containing zinc finger protein gene, maps to mouse chromosome 7. | 2.81e-05 | 3 | 107 | 2 | 7849402 | |
| Pubmed | Topoisomerase IIα mediates TCF-dependent epithelial-mesenchymal transition in colon cancer. | 2.81e-05 | 3 | 107 | 2 | 26947016 | |
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 25659031 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 20840855 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 2733794 | ||
| Pubmed | In vivo transcriptional governance of hair follicle stem cells by canonical Wnt regulators. | 2.81e-05 | 3 | 107 | 2 | 24463605 | |
| Pubmed | Ethanol induction of CYP2A5: role of CYP2E1-ROS-Nrf2 pathway. | 2.81e-05 | 3 | 107 | 2 | 22552773 | |
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 8297477 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 8188299 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 11806752 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 8484736 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 20532534 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 11106424 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 8250953 | ||
| Pubmed | Regulation of CYP2A5 gene by the transcription factor nuclear factor (erythroid-derived 2)-like 2. | 2.81e-05 | 3 | 107 | 2 | 17303623 | |
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 2703500 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 24013724 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 1417950 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 19854836 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 24045421 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 37480305 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 32987105 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 34525377 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 24349352 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 1973143 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 22217847 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 2765478 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 21252290 | ||
| Pubmed | Mitochondrial targeting of bilirubin regulatory enzymes: An adaptive response to oxidative stress. | 2.81e-05 | 3 | 107 | 2 | 25478736 | |
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 2415518 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 32403323 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 17466327 | ||
| Pubmed | Differential distribution of CYP2A6 and CYP2A13 in the human respiratory tract. | 2.81e-05 | 3 | 107 | 2 | 22890016 | |
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 32877213 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 24191237 | ||
| Pubmed | Generation and characterization of a novel Cyp2a(4/5)bgs-null mouse model. | 2.81e-05 | 3 | 107 | 2 | 23073733 | |
| Cytoband | 9q21.11 | 7.29e-07 | 30 | 107 | 4 | 9q21.11 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | VN1R4 CYP2A6 SRRM5 CYP2A13 GGN ZNF507 CCDC61 SSC5D SPINT2 KLC3 | 4.85e-04 | 1192 | 107 | 10 | chr19q13 |
| GeneFamily | Zinc fingers RANBP2-type |RNA binding motif containing | 1.97e-03 | 21 | 57 | 2 | 89 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 2.54e-03 | 181 | 57 | 4 | 694 | |
| GeneFamily | GCN5 related N-acetyltransferases | 2.58e-03 | 24 | 57 | 2 | 1134 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | TANC2 FKBP15 PCLO NPAS3 TATDN2 ANO8 FOXD4L5 NRP2 PACS1 FRY NRXN3 SPINT2 SCN9A AUTS2 RIMS1 CAMTA1 | 8.30e-06 | 1106 | 105 | 16 | M39071 |
| Coexpression | GSE40274_FOXP3_VS_FOXP3_AND_LEF1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN | 1.64e-05 | 200 | 105 | 7 | M9188 | |
| Coexpression | MIKKELSEN_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3 | 2.77e-05 | 217 | 105 | 7 | MM861 | |
| ToppCell | Substantia_nigra-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cspg5_(Cspg5)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 2.59e-06 | 90 | 107 | 5 | 3817a5b0235e632d976ea565175bdbebbd959bf0 | |
| ToppCell | Substantia_nigra-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cspg5_(Cspg5)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 2.59e-06 | 90 | 107 | 5 | a528f5dcee1a356dea89ff2588d2e0f276f2d5fc | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.51e-06 | 170 | 107 | 6 | 60bbd738c12e64e483485586c30057304884f5a6 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.72e-06 | 179 | 107 | 6 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L5-6_SST_KLHL14|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.36e-06 | 183 | 107 | 6 | 439b1d1373b7cc73d65f3b59037a6def7cf8f4ba | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D175|Adult / Lineage, Cell type, age group and donor | 6.26e-06 | 188 | 107 | 6 | ec38def1fdbb34ed9b30244806975bd5a4370164 | |
| ToppCell | mild-low-quality_cells|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.17e-06 | 197 | 107 | 6 | e4331969bd911d1ebb5453f40a7057297b5389b4 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.41e-06 | 198 | 107 | 6 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-B3GAT2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 8.91e-06 | 200 | 107 | 6 | 858421b91f5207b7934b5c219752cb9322a3da31 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-B3GAT2-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 8.91e-06 | 200 | 107 | 6 | a7022762c1d8aedb7b3e9605873b1e68b9907b35 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-1m-Mesenchymal-Mesoderm|1m / Sample Type, Dataset, Time_group, and Cell type. | 8.91e-06 | 200 | 107 | 6 | c0ad32e9dd7f481c2665587fd8bd9fffc2e725f9 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-B3GAT2--L4-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 8.91e-06 | 200 | 107 | 6 | 2131c8e7fa054b79906eaf60536da892438b09cd | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 5.50e-05 | 169 | 107 | 5 | 78eb70dd916724e476eabccf18fb7fcec4210308 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 6.49e-05 | 175 | 107 | 5 | fd8b5b756f3df4a04938785f3d9edbb6f1cd20f6 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|368C / Donor, Lineage, Cell class and subclass (all cells) | 6.49e-05 | 175 | 107 | 5 | 36c140540497bbe1c5f08fac2d94f08cac18fabb | |
| ToppCell | facs-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l49|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.03e-05 | 178 | 107 | 5 | cb9a446c145b1435cfe12a1d4568aed0924a6a20 | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-basal_late|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 7.03e-05 | 178 | 107 | 5 | 03f22485074b3cbf9a6ad4d543c5bbfa826dc741 | |
| ToppCell | wk_20-22-Hematologic-Myeloid-aDC_1|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 7.03e-05 | 178 | 107 | 5 | fd2bdb4796e86c8cff2d25f0c730ffea21db8787 | |
| ToppCell | MatrixFB-Fibroblast-A|MatrixFB / shred on cell class and cell subclass (v4) | 7.41e-05 | 180 | 107 | 5 | adc64ad6033af705dd7b9163a83e20ef5c59f6eb | |
| ToppCell | 343B-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 7.81e-05 | 182 | 107 | 5 | c98da2db197b1531204e116600ff51891e5c17af | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.81e-05 | 182 | 107 | 5 | 3f1a666fe27dd7529c114539ed5f6b8ca585c875 | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.01e-05 | 183 | 107 | 5 | bc24145855bf4d027a8058bf92bc796c10f241bb | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.01e-05 | 183 | 107 | 5 | 4c325ee6da070513097a11445ec95b0415ffd8a2 | |
| ToppCell | Control-Epithelial-Club|Epithelial / Disease state, Lineage and Cell class | 8.43e-05 | 185 | 107 | 5 | 6814b3c94c7558443c038a227b5c8563d2cfeac4 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.65e-05 | 186 | 107 | 5 | 1094c7140131454b2583200e1c01e81ccab3db23 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 8.65e-05 | 186 | 107 | 5 | 9d3efe2a4feea2bc205a7e45b9b9f9ed9b3609ce | |
| ToppCell | pdx-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 8.87e-05 | 187 | 107 | 5 | 7e376831a11ee72ed87abcdac631ca46ae29c250 | |
| ToppCell | droplet-Lung-immune-endo-depleted|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.32e-05 | 189 | 107 | 5 | c3fb363bb0156ffb3367c200f548faebda64ab4a | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.32e-05 | 189 | 107 | 5 | 06c44746fa4f02e6e2b3b635cdf2d8dfef3754d3 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.32e-05 | 189 | 107 | 5 | 2a2953f6b1b7d070d739dcaf7285fce6e097d9e4 | |
| ToppCell | PND07-28-samps-Mesenchymal-Matrix_fibroblast|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 9.32e-05 | 189 | 107 | 5 | dc5164591dea45b420798b94dda211be03daa70c | |
| ToppCell | PND07-28-samps-Mesenchymal-Matrix_fibroblast-FB-3|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 9.56e-05 | 190 | 107 | 5 | 1196b8ea2c44c7c80f5ee589dd517e6a413f2077 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.56e-05 | 190 | 107 | 5 | 9cd147a174017ebda23cc47b6d4552d898acd092 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-F_(Lymphatics)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.00e-04 | 192 | 107 | 5 | b016e229300c183e14c0e2bba494bf49c7899112 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-F_(Lymphatics)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.00e-04 | 192 | 107 | 5 | ac96831492c62ad9e1f7d0b764fbdf7d8a189ad9 | |
| ToppCell | facs-Lung-EPCAM-18m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-04 | 193 | 107 | 5 | b9ac74357435f2f24aaede62b2a1d31b5d96a12c | |
| ToppCell | Epithelial-club_cell|World / Lineage, Cell type, age group and donor | 1.03e-04 | 193 | 107 | 5 | 2bdd09004fa433550958ec42ba4b06271a4aaf7c | |
| ToppCell | Neuron-Postmitotic-Inhibitory_Neuron-MGE2|World / Primary Cells by Cluster | 1.05e-04 | 194 | 107 | 5 | b42fd64b0fb95434a9e4e6586f31d26114a4074b | |
| ToppCell | Neuron-Postmitotic-Inhibitory_Neuron-MGE2-10|World / Primary Cells by Cluster | 1.05e-04 | 194 | 107 | 5 | 81e7bc6516ab8d02ccd1c76a56a3533b788c27c8 | |
| ToppCell | PND01-03-samps-Mesenchymal|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 1.05e-04 | 194 | 107 | 5 | 4f9bd0ded0dde1df885850714f29e73e992539a5 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.08e-04 | 195 | 107 | 5 | 6095bb237d7bc75cbaeaeb492f6948f3c3fa4848 | |
| ToppCell | E17.5-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.08e-04 | 195 | 107 | 5 | b072fdc2131173f562e55dd78226eaf2c57d3690 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.11e-04 | 196 | 107 | 5 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | wk_08-11-Epithelial-Airway_epithelial_progenitor-epi-airway_progenitor_early|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.13e-04 | 197 | 107 | 5 | 4ae08ccb6f1da626c4f0fb0140a2811cb6e31ba1 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Neuronal-ventral_progenitors_and_neurons_1|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 1.13e-04 | 197 | 107 | 5 | 4961f66606f08e399508fd6cabca588e7ab406a8 | |
| ToppCell | normal_Lung-Epithelial_cells-Club|Epithelial_cells / Location, Cell class and cell subclass | 1.16e-04 | 198 | 107 | 5 | a9d0109ca05eb3e9c588f9677ec471dd5c092a75 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.16e-04 | 198 | 107 | 5 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | Biopsy_IPF-Epithelial-SCGB3A2+_SCGB1A1+|Biopsy_IPF / Sample group, Lineage and Cell type | 1.19e-04 | 199 | 107 | 5 | c6150f5fe2ce4466149a4d553acb907034a72efb | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 1.19e-04 | 199 | 107 | 5 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | NS-control-d_0-4-Epithelial-Secretory|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.19e-04 | 199 | 107 | 5 | 32bdfff40fd442b88489c8b0f79af3927a51a03c | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 1.19e-04 | 199 | 107 | 5 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | control-Epithelial-Secretory|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.19e-04 | 199 | 107 | 5 | 262e5b8a52c8ddb0b47048c786e8bdb7158e1b9a | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW10-Stem_cells|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 1.22e-04 | 200 | 107 | 5 | 474e6ab48f199315f3cca86b81fdf54e0461b7b8 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 1.22e-04 | 200 | 107 | 5 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | 10x5'v1-week_14-16-Endothelial-stroma-sinusoidal_EC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.22e-04 | 200 | 107 | 5 | ae429f2de652cc1976e63644781197e9ce0e70c8 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW10-Stem_cells-Stem_cells|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 1.22e-04 | 200 | 107 | 5 | 01a29651e9bb64ef7666c6a61ec396eeb88b2816 | |
| Disease | cortical surface area measurement | TANC2 TCF7L2 LINC02881 NPAS3 TRIOBP MARCHF7 ST7L C17orf58 MLF2 SPINT2 MDC1 PKD1 AUTS2 TCF7L1 | 1.42e-04 | 1345 | 98 | 14 | EFO_0010736 |
| Disease | obesity | 1.57e-04 | 241 | 98 | 6 | EFO_0001073 | |
| Disease | Opitz GBBB syndrome (implicated_via_orthology) | 1.62e-04 | 6 | 98 | 2 | DOID:0080697 (implicated_via_orthology) | |
| Disease | pack-years measurement, systolic blood pressure | 1.97e-04 | 34 | 98 | 3 | EFO_0006335, EFO_0006526 | |
| Disease | Neurodevelopmental Disorders | 2.66e-04 | 93 | 98 | 4 | C1535926 | |
| Disease | trauma exposure measurement | 2.78e-04 | 172 | 98 | 5 | EFO_0010703 | |
| Disease | total cholesterol measurement, response to escitalopram, response to citalopram | 3.02e-04 | 8 | 98 | 2 | EFO_0004574, EFO_0006329, EFO_0007871 | |
| Disease | Inherited neuropathies | 3.21e-04 | 40 | 98 | 3 | C0598589 | |
| Disease | neuroticism measurement, cognitive function measurement | 6.05e-04 | 566 | 98 | 8 | EFO_0007660, EFO_0008354 | |
| Disease | lobe attachment | 6.48e-04 | 207 | 98 | 5 | EFO_0007667 | |
| Disease | tuberculin skin test reactivity measurement, decreased susceptibility to bacterial infection | 7.05e-04 | 12 | 98 | 2 | EFO_0008307, EFO_0008322 | |
| Disease | chronotype measurement | TANC2 CYP2A6 TCF7L2 CCDC61 HP1BP3 NRXN3 DCHS1 AUTS2 RIMS1 CAMTA1 | 7.07e-04 | 882 | 98 | 10 | EFO_0008328 |
| Disease | Intellectual Disability | 7.39e-04 | 447 | 98 | 7 | C3714756 | |
| Disease | systolic blood pressure, cigarettes per day measurement | 8.32e-04 | 13 | 98 | 2 | EFO_0006335, EFO_0006525 | |
| Disease | COVID-19, coronary artery disease | 8.32e-04 | 13 | 98 | 2 | EFO_0001645, MONDO_0100096 | |
| Disease | DEAFNESS, AUTOSOMAL RECESSIVE (disorder) | 8.32e-04 | 13 | 98 | 2 | C1846647 | |
| Disease | aspartate aminotransferase measurement | CYP2A6 ARHGEF19 MARCHF7 POLR2M PHLDA2 ST7L ITPR1 GLI1 TCF7L1 TJP3 | 8.53e-04 | 904 | 98 | 10 | EFO_0004736 |
| Disease | autosomal dominant polycystic kidney disease (implicated_via_orthology) | 9.68e-04 | 14 | 98 | 2 | DOID:898 (implicated_via_orthology) | |
| Disease | Schizoaffective disorder-bipolar type | 1.27e-03 | 16 | 98 | 2 | EFO_0009965 | |
| Disease | rosacea severity measurement | 1.49e-03 | 147 | 98 | 4 | EFO_0009180 | |
| Disease | gait measurement | 1.60e-03 | 150 | 98 | 4 | EFO_0007680 | |
| Disease | facial asymmetry measurement | 1.80e-03 | 19 | 98 | 2 | EFO_0009751 | |
| Disease | heart failure, diabetes mellitus, stroke, atrial fibrillation, mortality, coronary artery disease, cancer | 2.00e-03 | 20 | 98 | 2 | EFO_0000275, EFO_0000400, EFO_0000712, EFO_0001645, EFO_0003144, EFO_0004352, MONDO_0004992 | |
| Disease | unipolar depression | TCF7L2 PCLO PCARE STMND1 WDPCP ANO8 TRIL PKD1 DCHS1 AUTS2 CAMTA1 | 2.21e-03 | 1206 | 98 | 11 | EFO_0003761 |
| Disease | squamous cell lung carcinoma | 2.26e-03 | 165 | 98 | 4 | EFO_0000708 | |
| Disease | prostate carcinoma | 2.87e-03 | 891 | 98 | 9 | EFO_0001663 | |
| Disease | neuroimaging measurement | TCF7L2 LINC02881 ST7L C17orf58 HP1BP3 NRP2 CBFA2T2 RLIM PKD1 CAMTA1 | 2.93e-03 | 1069 | 98 | 10 | EFO_0004346 |
| Disease | body weight | IPPK TCF7L2 RTTN ITPR1 NRXN3 KIAA1217 DGKK PKD1 AUTS2 SENP6 ZRANB1 | 3.11e-03 | 1261 | 98 | 11 | EFO_0004338 |
| Disease | response to mTOR inhibitor | 3.12e-03 | 25 | 98 | 2 | EFO_0005417 | |
| Disease | non-Hodgkins lymphoma | 3.12e-03 | 25 | 98 | 2 | EFO_0005952 | |
| Disease | coffee consumption measurement | 3.22e-03 | 182 | 98 | 4 | EFO_0006781 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RENEPDSQGPIQRRS | 146 | Q96MC4 | |
| QASRREERAPPNSSL | 591 | Q8N715 | |
| PPTREDRASSSRERS | 291 | Q9Y6R9 | |
| STNPELRRPRSEPSN | 1216 | Q9Y6Y1 | |
| PQASDANREPVAERS | 81 | Q76N32 | |
| QRTLDPNSPRDFIDS | 256 | P11509 | |
| EQRSRGVTDTREPSP | 391 | Q9P209 | |
| TSAEARPETRAQPSS | 1616 | Q2TAZ0 | |
| DPEPGSNSDSTRRQR | 696 | Q9HCE9 | |
| SRNRKNRSSAVDPEP | 241 | Q5SSJ5 | |
| DREVQAEQPSSSSPR | 176 | Q9Y388 | |
| SQQEGLSRDRPSPES | 171 | Q8WWW0 | |
| ASSDQRPVVPSSRSR | 416 | Q9H8X2 | |
| EEPPLGSRSTNERRQ | 271 | Q8IW93 | |
| AQTPRSEDARSSPSQ | 21 | P33991 | |
| PRFPRASSEATIREN | 2066 | Q96JQ0 | |
| DPEDINQTSPRRRSR | 806 | Q5KSL6 | |
| ERSSPAGRDPTRQDA | 251 | Q5SZI1 | |
| LPRTNTPARASEARS | 566 | Q7Z4F1 | |
| TPEPTSQATRGRTDR | 1466 | Q14676 | |
| RDQAEEEPNRIPSRS | 1866 | Q14676 | |
| EAPSQRRLRSPNDDI | 261 | Q92831 | |
| PSVDPDQDASRSRLR | 331 | Q14643 | |
| RAPPRSAAASEDARQ | 91 | Q8WXT5 | |
| RAPPRSAAASEDARQ | 91 | Q6VB84 | |
| AQAENRASPRREPAS | 106 | Q2M2W7 | |
| RSQSADAPGPTERER | 156 | Q9NSC5 | |
| RESEPRPTSARQLDG | 41 | Q96DC8 | |
| PSPERREENSFDRDT | 236 | O43439 | |
| SSESENSPVPQRKRR | 1516 | Q9Y6V0 | |
| TARDAEPSSETRPQE | 21 | Q8N8M0 | |
| RPRRPSQEQSASASS | 951 | Q5T1M5 | |
| SSSSPNDRTFPDDRN | 671 | O60462 | |
| PANDRPSTRSDRLAV | 1106 | Q9Y4C0 | |
| SARPNSTSSREAEPR | 951 | Q8WXX7 | |
| TRRASDPAQAADRPA | 636 | P08151 | |
| QAREGPSRETSPREA | 431 | Q9UGJ1 | |
| ESQQSESPPRRDSLA | 161 | Q6P597 | |
| KVQPSDRAPDSRRTS | 16 | Q86UU5 | |
| ERRRRPESSSSPESS | 211 | P31270 | |
| PQAETREAREAARSP | 36 | Q9Y3T9 | |
| PLSERTNSSDSERSP | 521 | Q6VY07 | |
| QKQASSRSRSEPPRE | 256 | Q86UR5 | |
| RDQDRESPSTRPSTP | 531 | Q3KR16 | |
| SRASSPLPRQDRDSF | 16 | O95876 | |
| NTSSHNRPDARDPRS | 441 | P08887 | |
| APNAQRRTPDSTFSE | 201 | Q9NZI5 | |
| QRTLDPNSPRDFIDS | 256 | Q16696 | |
| PRRKRQPSSSSEDSD | 141 | Q96C57 | |
| ETNSSARPARRAPDE | 611 | Q9BQN1 | |
| DRRPDTTAPLTDRQT | 26 | Q96JB2 | |
| APQNAPRDESRGRSS | 306 | Q9NYF8 | |
| SDPRSSERDQLRPGD | 681 | Q6ZU35 | |
| PRRQRSDQDSDSDQP | 1076 | Q6PD62 | |
| SRSNVPSASEVPDNR | 326 | Q9H992 | |
| RGETRCEQDRPSPTT | 186 | P11279 | |
| SNFVRSPSQRLDPSR | 416 | Q9BZB8 | |
| IDRSSDPPRSATLDR | 1991 | Q5TBA9 | |
| PQDNPSSRDDRGRVR | 126 | Q9Y6H8 | |
| SSNRDRVPPSSEASE | 156 | P0CAP2 | |
| AEDDIQPSPRRARSS | 251 | Q92902 | |
| SRPEESSQSRDSAPS | 4246 | Q9NZJ4 | |
| AIQGPEDSPSRQSRR | 231 | Q15773 | |
| RLRSPRDSQTEPQND | 6 | E9PI22 | |
| NGSEPESRSPDNRTQ | 621 | P98161 | |
| SSPADRESPFQARTR | 516 | A6NGG8 | |
| PNTTGSSRREAPRDV | 96 | P0DMQ5 | |
| GAVSPDSRPETRRQT | 6 | Q8N912 | |
| RAPSRTSQDRDPSSL | 1531 | Q86VV8 | |
| DVAPSSRPAQRSASR | 31 | Q93075 | |
| RDQAEDPASSPTSKR | 996 | Q6IEE7 | |
| RTGSTQSPRTQPRDE | 666 | Q8N5C8 | |
| PRNQESSSDEQTPSR | 1291 | P30414 | |
| QTPSRDDDSQSRSPS | 1301 | P30414 | |
| PANDRPSTRSDRLAV | 101 | Q9HDB5 | |
| RAPPRSAAASEDARQ | 91 | Q5VV16 | |
| RAPPRSAAASEDARQ | 91 | Q3SYB3 | |
| ERRSSNISQASRSPP | 596 | Q15858 | |
| ARSQPEDTPENTVRR | 1626 | Q5T5P2 | |
| REQRASREPEPGSAS | 71 | A0A2R8YCJ5 | |
| SEEPPDRRQSSVDSR | 26 | Q9HCD6 | |
| PSFQQDPSRRERITA | 6 | Q8IXF0 | |
| PTDSNNSTPREAASR | 416 | A1L4H1 | |
| RLRSPRDSQTEPQND | 6 | P0DMB1 | |
| RASSPSRSTQLDNPR | 341 | Q9H2D6 | |
| DDPRASSPNRTTQRE | 386 | Q9H2D6 | |
| DNPRASSPSRATRDN | 436 | Q9H2D6 | |
| TSSPNRATRDNPRTS | 466 | Q9H2D6 | |
| ASRTSSPNRATRDNP | 561 | Q9H2D6 | |
| RASSPNRATRDNPTT | 586 | Q9H2D6 | |
| DNPRASRTSSPNRAT | 606 | Q9H2D6 | |
| AQRDDPRASSPNRTT | 701 | Q9H2D6 | |
| DNPRTSSPNRATRDN | 776 | Q9H2D6 | |
| TSDSPVAEDASRRRP | 56 | P55789 | |
| PRPRQDSAAGNSEER | 31 | B7Z368 | |
| ESEPTSRRQCRNSPG | 456 | Q9NX65 | |
| PRTSNRERSDSQPRN | 176 | B3KS81 | |
| QSSSSDSEAERRPQP | 76 | Q9HCS4 | |
| EQQPSSASERQAPRA | 2056 | P12270 | |
| ADSSVPSAPRRQDSE | 106 | O43291 | |
| AADASRRPDSRPVRS | 46 | Q96MI6 | |
| VENPRSESTSARPSR | 176 | Q9NVW2 | |
| TRAPRSSSQEQEPSA | 1141 | Q7Z6L1 | |
| VSGPNSPSETRRERA | 91 | O15344 | |
| DPSPSASLTADRRRQ | 416 | Q7L0X0 | |
| QNSSSDSEAERRPPP | 56 | Q9NQB0 | |
| NAEPADRDSPRTARQ | 411 | Q3KQV9 | |
| DNDRTNRRESISPQP | 341 | Q9GZR1 | |
| SEPGSPSRNRENETS | 131 | Q8TDW4 | |
| IDRSDLSPRASPENR | 216 | Q7Z5H5 | |
| RSRQERTAPAAPAED | 111 | Q53GA4 | |
| RSSDESNFDVPPRET | 1301 | P11388 | |
| SEPVQADESQSPRDR | 846 | O95049 | |
| ENAPPGRRRTNSESL | 476 | Q8TCN5 | |
| SENSPSPSERNRRVN | 71 | H3BQB6 | |
| RLQSRSRPSAPETDD | 21 | Q9Y4F4 | |
| VSGPNSPSESRRERT | 111 | Q9UJV3 | |
| RAPDSRPEEALDSSR | 156 | Q4V9L6 | |
| DNSARDSLRISDPSP | 291 | P0DJG4 | |
| SSPSQDAQDARRPRS | 326 | Q8N228 | |
| DAQDARRPRSRNPSA | 331 | Q8N228 | |
| NSQRRSPPATKRDSE | 211 | Q9UGI0 | |
| PRTTAVSSNRNPEDD | 271 | Q8N7P7 |